STEPHEN A SHERWIN Insider Trading
Get free email notifications about insider trading for STEPHEN A SHERWIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEPHEN A SHERWIN. STEPHEN A SHERWIN is a Chairman & C.E.O. in CELL GENESYS INC ($CEGE) and a Chairman & Chief Exec. Officer in CELL GENESYS INC ($CEGE) and a Chairman and CEO in CELL GENESYS INC ($CEGE) and a Director in VICAL INC ($VICL) and a Director in BIOGEN INC. ($IDPH) and a Director in NEUROCRINE BIOSCIENCES INC ($NBIX) and a Director in RIGEL PHARMACEUTICALS INC ($RIGL) and a Director in ADURO BIOTECH, INC. ($ADRO) and a Director in Verastem, Inc. ($VSTM) and a Director in Neon Therapeutics, Inc. ($NTGN).
Address: C/O CELL GENESYS, INC. 500 FORBES BLVD. SOUTH SAN FRANCISCO 94080 CA
Companies in which STEPHEN A SHERWIN is an Insider
BIOGEN INC.
Trading Symbol: IDPHIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STEPHEN A SHERWIN: Director
Holdings: 16,328 shares
Latest Transaction: Jun 05 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Brickell Biotech, Inc.
Trading Symbol: VICLIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STEPHEN A SHERWIN: Director
Holdings: 22,003 shares
Current Value: $46,866
Latest Transaction: May 26 2015
$VICL Market Capitalization: $24.86M
$VICL Previous Close: $2.13
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CELL GENESYS INC
Trading Symbol: CEGEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEPHEN A SHERWIN: Chairman and CEO, Chairman & C.E.O., Chairman & Chief Exec. Officer
Holdings: 0 shares
Latest Transaction: Oct 15 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CHINOOK THERAPEUTICS, INC.
Trading Symbol: ADROIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEPHEN A SHERWIN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 28 2020
$ADRO Market Capitalization: $745.72M
$ADRO Previous Close: $11.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Neon Therapeutics, Inc.
Trading Symbol: NTGNIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STEPHEN A SHERWIN: Director
Holdings: 0 shares
Latest Transaction: May 06 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NEUROCRINE BIOSCIENCES INC
Trading Symbol: NBIXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STEPHEN A SHERWIN: Director
Holdings: 29,861 shares
Current Value: $1,301,940
Latest Transaction: May 21 2020
$NBIX Market Capitalization: $3.81B
$NBIX Previous Close: $43.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RIGEL PHARMACEUTICALS INC
Trading Symbol: RIGLIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEPHEN A SHERWIN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 12 2016
$RIGL Market Capitalization: $237.45M
$RIGL Previous Close: $2.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Verastem, Inc.
Trading Symbol: VSTMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEPHEN A SHERWIN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 16 2015
$VSTM Market Capitalization: $44.39M
$VSTM Previous Close: $1.24
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of STEPHEN A SHERWIN
Sentiment: All, IDPH, VICL, CEGE, ADRO, NTGN, NBIX, RIGL, VSTM
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 05 2020 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Grant | A | 0.00 | 890 | 0 | 16,328 | 15.4 K to 16.3 K (+5.76 %) |
May 28 2020 | ADRO | ADURO BIOTECH, INC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 3.00 | 30,000 | 90,000 | 30,000 | |
May 21 2020 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 119.93 | 6,018 | 721,739 | 6,018 | |
May 06 2020 | NTGN | Neon Therapeutics, ... | SHERWIN STEPHEN A | Director | Option Exercise | D | 2.65 | 5,000 | 13,250 | 0 | |
May 06 2020 | NTGN | Neon Therapeutics, ... | SHERWIN STEPHEN A | Director | Option Exercise | D | 4.64 | 18,500 | 85,840 | 0 | |
May 06 2020 | NTGN | Neon Therapeutics, ... | SHERWIN STEPHEN A | Director | Option Exercise | D | 16.00 | 14,000 | 224,000 | 0 | |
May 06 2020 | NTGN | Neon Therapeutics, ... | SHERWIN STEPHEN A | Director | Sell | D | 0.00 | 45,000 | 0 | 0 | 45 K to 0 (-100.00 %) |